Buscar resultados de ensayos clínicos
Neurofibromatosis Type 2 - 1 Studies Found
| Estado | Estudiar |
| Completed |
Nombre del estudio: Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity Condición: Malignant Pleural Mesothelioma Fecha: 2009-12-02 Intervenciones: Drug: everolimus Everolimus will be administered at a dose of 10mg orally once daily continuously. Dose |